“Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor”. 2023. Precision Medicine Communications 3 (1): 27-42. https://doi.org/10.55627/pmc.003.01.0296.